Tenon Medical CATAMARAN™ SI Joint Fusion System CT Scan Study

Last updated: April 19, 2023
Sponsor: Tenon Medical
Overall Status: Active - Enrolling

Phase

N/A

Condition

Ankylosing Spondylitis

Treatment

N/A

Clinical Study ID

NCT05628142
PTL016
  • Ages > 18
  • All Genders

Study Summary

The objective of this study is to evaluate 6-to-12-month radiographic outcomes of patients with sacroiliac joint disruptions or degenerative sacroiliitis that have already undergone treatment with the CATAMARAN SI Joint Fusion System. In addition, retrospective and prospective clinical outcomes will be evaluated.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient >18 years of age at time of treatment with the CATAMARAN SI Joint FusionSystem
  • Patient implanted with the CATAMARAN Fixation Device within the last 12 months
  • Diagnosis of sacroiliac joint disruption or degenerative sacroiliitis
  • Patient, or authorized representative, signs a written Informed Consent form toparticipate in the study
  • Patient is willing and able to complete study follow-up requirements

Exclusion

Exclusion Criteria:

  • Known or suspected active drug or alcohol abuse
  • Previously diagnosed osteoporosis (defined as prior T-score <-2.5 or history ofosteoporotic fracture) or prior/current use of drug therapy for osteoporosis.
  • Prior fracture of any bone related to cancer/tumor (i.e., pathologic fracture)
  • Prior diagnosis of tumor in sacrum or ilium
  • Unstable fracture of sacrum and or ilium involving the targeted SIJ
  • Osteomalacia or other metabolic bone disease
  • Use of medications known to have detrimental effects on bone quality and soft-tissuehealing
  • Patient is pregnant or wishes to become pregnant during the study period
  • Patient is not likely to comply with the follow-up evaluation schedule
  • Patient is a prisoner or a ward of the state

Study Design

Total Participants: 50
Study Start date:
November 01, 2022
Estimated Completion Date:
November 30, 2024

Study Description

Patients with degenerative sacroiliitis or sacroiliac joint disruption who already had the CATAMARAN Fixation Device implanted between 6 and 12 months will be asked to return for follow-up visit to evaluate clinical outcomes and undergo a high resolution pelvic CT-Scan to assess fusion. Additionally, retrospective clinical outcomes will be collected from the medical records.

Connect with a study center

  • Minimally Invasive Neurosurgery of Texas

    Plano, Texas 75024
    United States

    Site Not Available

  • St. George Orthopaedic Spine

    Saint George, Utah 84790
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.